By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GenMark Diagnostics today said that it has filed with the US Food and Drug Administration for 510(k) clearance of its Respiratory Viral Panel.

The test would run on the firm's eSensor XT-8 and is designed to identify multiple viruses from patients exhibiting symptoms of respiratory infection. The Carlsbad, Calif.-based firm previously stated that the test would detect 21 upper respiratory viruses.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.